创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Introduction to murine-derived immune system models

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-05 14:33
  • Views:

(Summary description)With the development of biotechnology, the study of the immune system has become an important topic in the field of life sciences. The mouse-derived immune system model developed by InnoModels Biotechnology, with its unique advantages, provides researchers with a brand new research tool. The model uses mice as a model to simulate the structure and function of the real human immune system, which provides an important experimental platform for research in the fields of immunology, oncology and vaccine development

InnoModels Biotechnology: Introduction to murine-derived immune system models

(Summary description)With the development of biotechnology, the study of the immune system has become an important topic in the field of life sciences. The mouse-derived immune system model developed by InnoModels Biotechnology, with its unique advantages, provides researchers with a brand new research tool. The model uses mice as a model to simulate the structure and function of the real human immune system, which provides an important experimental platform for research in the fields of immunology, oncology and vaccine development

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-05 14:33
  • Views:
Information

With the development of biotechnology, the study of the immune system has become an important topic in the field of life sciences. The mouse-derived immune system model developed by InnoModels Biotechnology, with its unique advantages, provides researchers with a brand new research tool. The model uses mice as a model to simulate the structure and function of the real human immune system, which provides an important experimental platform for research in the fields of immunology, oncology and vaccine development.

Features of the model

1. Highly simulate the human immune system: the mouse immune system model of InnoModels Biotechnology highly simulates the structure and function of the human immune system, which provides researchers with an immune environment closer to the real human body.
2. High accuracy: The model adopts advanced biological materials and manufacturing process, which ensures the accuracy and stability of the model and provides reliable experimental data for researchers.
3. High Repeatability: The model has a stable structure, is easy to operate, and has a high repeatability, providing researchers with a wider range of research.
4. High cost-effectiveness: Compared with human clinical trials, the use of models for experimental research is less costly, and the experimental data can be obtained more quickly, improving the efficiency of scientific research.

Application Areas

1. Immunological research: the model can be used to study the proliferation, migration, differentiation and other processes of immune cells, providing new perspectives and methods for immunological research.
2. Tumor immunotherapy: the model can be used to study the immune escape mechanism of tumor cells, providing new ideas and methods for tumor immunotherapy.
3. Vaccine research and development: the model can be used to study the immunogenicity of vaccines, assess the safety and effectiveness of vaccines, and provide powerful support for vaccine research and development.

 

 

Experimental effect

Through the experiments of the mouse-derived immune system model of InnoModels Biotechnology Company, researchers have achieved remarkable results. For example, through the model to study the immune escape mechanism of tumor cells, new regulatory factors have been discovered, providing new strategies for tumor treatment. Meanwhile, the model also plays an important role in vaccine development, providing strong support for the development of new vaccines.

Future Development

With the development of science and technology, InnoModels's mouse-derived immune system model will play a greater role in immunology, oncology, vaccine development and other fields. In the future, the model is expected to be applied to the construction of more disease models, providing new ideas and methods for disease prevention and treatment. Meanwhile, with the development of artificial intelligence and big data technology, the model is expected to be intelligent and personalized, providing more possibilities for individualized medicine.

Summary

The mouse-derived immune system model of InnoModels Biotechnology is an important achievement in the development of biotechnology, providing an important experimental platform for research in the fields of immunology, oncology and vaccine development. The model has the characteristics of highly simulating human immune system, high accuracy, repeatability, etc., as well as the advantage of high cost-effectiveness. Through the experiments of the model, researchers have achieved remarkable results and provided new ideas and methods for disease prevention and treatment. In the future, the model will play a greater role in more fields, providing more possibilities for individualized medicine and disease prevention.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司